Aller au contenu principal
Profil bibliographique

Qianyu Jing

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

16Publications signalées
105Citations signalées
3Affiliations récentes

Les institutions déclarées

Les domaines associés

Immunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionCancer, Stress, Anesthesia, and Immune ResponseTryptophan and brain disorders

Les publications récentes

Accès ouvert 2026 erratum OpenAlex

Correction: Ansofaxine hydrochloride inhibits tumor growth and enhances anti-TNFR2 in murine colon cancer model

Qianyu Jing, Quan Wan, Yujie Nie, Junqian Luo et autres

Colon cancer (CRC) is the fourth deadliest cancer worldwide, killing hundreds of thousands of people each year (1). At the same time, the mental health of patients is also attracting more and more attention, with the occurrence of depression in cancer patients …

cn (code pays fourni par la source)

0 citations Frontiers in Pharmacology
Accès ouvert 2026 article OpenAlex

3M-052 combined inhibitory anti-TNFR2 synergistically suppresses colon cancer progression

Qianyu Jing, Junqian Luo, Quan Wan, Qianjun Jing et autres

Introduction: Immunotherapy is considered the most promising approach for achieving complete tumor clearance in cancer treatment. However, monotherapy has demonstrated limited clinical efficacy, leading to a growing consensus that combination immunotherapy-activating the immune system through multiple pathways-appears to be the optimal strategy …

cn, hk (code pays fourni par la source)

0 citations Frontiers in Immunology
Accès ouvert 2025 article OpenAlex

Development of an early prediction model for risk of influenza A and influenza B based on complete blood count examination

Xiefei Hu, Chunmei Duan, Huajian Chen, Xun Li et autres

BACKGROUND: Influenza A (IAV) and B (IBV) viruses are the primary etiologic agents driving seasonal influenza epidemics and global pandemics. Early prediction plays a crucial role in epidemic control and reducing mortality rates. Complete blood count (CBC), a widely used clinical tool, …

cn (code pays fourni par la source)

2 citations BMC Infectious Diseases
Accès ouvert 2024 article OpenAlex

The combination of a PTP1B inhibitor, TNFR2 blocker, and PD‑1 antibody suppresses the progression of non‑small cell lung cancer tumors by enhancing immunocompetence

Huan Gui, Yujie Nie, Haohua Yuan, Qianyu Jing et autres

Lung cancer is increasingly recognized as a leading cause of cancer‑related mortality. Immunotherapy has emerged as a promising therapeutic approach for lung cancer, particularly non‑small cell lung cancer (NSCLC). Nonetheless, the response rate to programmed cell death 1 (PD‑1) inhibitors remains less …

cn (code pays fourni par la source)

9 citations Oncology Reports
Accès ouvert 2024 article OpenAlex

Regulating Tumor-Associated Macrophage Polarization by Cyclodextrin-Modified PLGA Nanoparticles Loaded with R848 for Treating Colon Cancer

Haohua Yuan, Huan Gui, Shuanghui Chen, Lan Zhu et autres

Purpose: This study aimed to develop a novel and feasible modification strategy to improve the solubility and antitumor activity of resiquimod (R848) by utilizing the supramolecular effect of 2-hydroxypropyl-beta-cyclodextrin (2-HP-β-CD). Methods: R848-loaded PLGA nanoparticles modified with 2-HP-β-CD (CD@R848@NPs) were synthesized using an …

cn (code pays fourni par la source)

31 citations International Journal of Nanomedicine

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.